谷氨酸脱羧酶
抑制性突触后电位
遗传增强
兴奋性突触后电位
转基因
帕尔瓦布明
癫痫
生物
谷氨酸
基因传递
细胞生物学
基因
药理学
神经科学
γ-氨基丁酸
化学
基因表达
癌症研究
神经递质
神经传递
神经元
分子生物学
加巴能
HEK 293细胞
作者
Yuuki Fukai,Ayumu Konno,Nobutake Hosoi,Karin Miyakawa,Ryosuke Kaneko,Hirokazu Hirai
标识
DOI:10.1016/j.ymthe.2026.06.007
摘要
Epilepsy arises from disruption of excitation-inhibition (E/I) balance, typically due to excessive excitatory activity. Despite available therapies, a substantial proportion of patients remain treatment resistant. Enhancing inhibitory neuron activity via gene therapy can restore E/I balance and may therefore provide a therapeutic strategy for treatment-resistant epilepsy. Here, we developed a compact 410-bp glutamic acid decarboxylase 67 promoter (cmGAD67) that enables strong, selective transgene expression in inhibitory neurons while preserving adeno-associated virus (AAV) packaging capacity. Systemic delivery of AAV vectors carrying cmGAD67 preferentially targeted parvalbumin interneurons and enabled efficient circuit modulation. To evaluate therapeutic potential, we expressed glutamic acid decarboxylase 65 (GAD65) under the control of cmGAD67 (AAV-GAD65). AAV-GAD65 suppressed abnormal delta oscillations, reduced seizure-like activity, normalized anxiety-like behavior, and improved survival in seizure models. Biochemical analyses confirmed increased GABA levels in the cortex and hippocampus, linking functional improvements to enhanced inhibitory neurotransmitter synthesis. Together, these findings establish the cmGAD67 promoter as a versatile platform for inhibitory neuron-targeted AAV gene delivery and identify AAV-GAD65 as a promising strategy for seizure control and disorders associated with E/I imbalance.
科研通智能强力驱动
Strongly Powered by AbleSci AI